Literature DB >> 15466343

Successful revascularization of acute carotid stent thrombosis by facilitated thrombolysis.

Sabine Steiner-Böker1, Manfred Cejna, Christian Nasel, Erich Minar, Christoph W Kopp.   

Abstract

A 64-year-old woman undergoing protected carotid artery stent placement developed acute stent thrombosis despite pretreatment with combined antiplatelet therapy. A reduced dose of recombinant tissue plasminogen activator and a half-dose bolus of abciximab were administered intra-arterially via superselective catherization followed by systemic intravenous infusion of abciximab for 12 hours. Control angiography showed complete restoration of blood flow paralleled by neurologic improvement.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15466343      PMCID： PMC7975469     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


  22 in total

Review 1.  Facilitated thrombolysis: dethrombosis?

Authors:  Héctor Luciardi; Sofía Berman; Juan Muntaner; Fernando de la Serna; Raúl Altman
Journal:  Clin Appl Thromb Hemost       Date:  2002-04       Impact factor: 2.389

2.  Abciximab in acute ischemic stroke. A randomized, double-blind, placebo-controlled, dose-escalation study.

Authors: 
Journal:  Stroke       Date:  2000-03       Impact factor: 7.914

3.  Acute basilar artery occlusion treated with combined intravenous Abciximab and intra-arterial tissue plasminogen activator: report of 3 cases.

Authors:  Bernd Eckert; Christoph Koch; Götz Thomalla; Joachim Roether; Herrmann Zeumer
Journal:  Stroke       Date:  2002-05       Impact factor: 7.914

4.  Carotid stent thrombosis: report of 2 fatal cases.

Authors:  S Chaturvedi; S Sohrab; A Tselis
Journal:  Stroke       Date:  2001-11       Impact factor: 7.914

5.  Initial experience of platelet glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting: a safe and effective adjunctive therapy.

Authors:  S R Kapadia; C T Bajzer; K M Ziada; D L Bhatt; O M Wazni; M J Silver; E G Beven; K Ouriel; J S Yadav
Journal:  Stroke       Date:  2001-10       Impact factor: 7.914

6.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

7.  Current status in cervical carotid artery stent placement.

Authors:  M H Wholey; M Wholey
Journal:  J Cardiovasc Surg (Torino)       Date:  2003-06       Impact factor: 1.888

8.  Effect of glycoprotein IIb/IIIa antagonist abciximab on monocyte-platelet aggregates and tissue factor expression.

Authors:  Sabine Steiner; Daniela Seidinger; Kurt Huber; Christoph Kaun; Erich Minar; Christoph W Kopp
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-07-17       Impact factor: 8.311

9.  An additional mechanism of action of abciximab: dispersal of newly formed platelet aggregates.

Authors:  Stanley J Marciniak; Mary A Mascelli; Mark I Furman; Alan D Michelson; Joseph A Jakubowski; Robert E Jordan; Peter J Marchese; Andrew L Frelinger
Journal:  Thromb Haemost       Date:  2002-06       Impact factor: 5.249

10.  Local intra-arterial fibrinolysis of thromboemboli occurring during neuroendovascular procedures with recombinant tissue plasminogen activator.

Authors:  Stefan Hähnel; Peter D Schellinger; Alexander Gutschalk; Karsten Geletneky; Marius Hartmann; Michael Knauth; Klaus Sartor
Journal:  Stroke       Date:  2003-06-12       Impact factor: 7.914
View more
  8 in total

1.  Superselective intracerebral catheterization of a branch of the internal carotid artery coupled with magnetic resonance imaging.

Authors:  J Pryor; H D'Arceuil; M Phil; J Liu; J He; R G Gonzalez; M Duggan; A De Crespigny
Journal:  Interv Neuroradiol       Date:  2007-09-15       Impact factor: 1.610

2.  Recanalization of acute carotid stent occlusion using Penumbra 4Max aspiration catheter: technical report and review of rescue strategies for acute carotid stent occlusion.

Authors:  Stephan Munich; Roham Moftakhar; Demetrius Lopes
Journal:  BMJ Case Rep       Date:  2013-10-14

3.  Hyperacute Carotid Stent Thrombosis During Emergent Revascularization Treated with Intraarterial Eptifibatide After Systemic Administration of Recombinant Tissue Plasminogen Activator.

Authors:  Grant C Sorkin; Travis M Dumont; Maxim Mokin; Jorge L Eller; Sabareesh K Natarajan; Elad I Levy; Adnan H Siddiqui
Journal:  J Vasc Interv Neurol       Date:  2015-07

4.  Rescue use of tirofiban for acute carotid in-stent thrombosis.

Authors:  Kwon Duk Seo; Kee Oog Lee; Dong Joon Kim; Kyung-Yul Lee
Journal:  Yonsei Med J       Date:  2008-02-29       Impact factor: 2.759

5.  Revascularization of acute stent thrombosis after carotid artery stenting in a CYP2C19*2 heterozygote patient.

Authors:  Wei Wei; Yan Wang; Pian Wang; Zheng Li
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

6.  Acute carotid stent thrombosis: A case report and literature review.

Authors:  Jian-Bin Zhang; Xue-Qiang Fan; Jie Chen; Peng Liu; Zhi-Dong Ye
Journal:  World J Clin Cases       Date:  2022-09-16       Impact factor: 1.534

7.  Acute In-Stent Thrombosis after Carotid Angioplasty and Stenting: A Case Report and Literature Review.

Authors:  Wei Hu; Li Wang; GuoPing Wang
Journal:  Interv Neurol       Date:  2018-04-03

8.  How Safe is Eptifibatide during Urgent Carotid Artery Stenting?

Authors:  Hesham Allam; Nirav Vora; Randall C Edgell; R Charles Callison; Yasser Al Khalili; Michelle Storkan; Amer Alshekhlee
Journal:  Front Neurol       Date:  2013-02-12       Impact factor: 4.003
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.